Adage Capital Partners’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-420,706
| Closed | -$45.2M | – | 980 |
|
|
2023
Q1 | $45.2M | Sell |
420,706
-681,133
| -62% | -$73.1M | 0.1% | 235 |
|
|
2022
Q4 | $121M | Sell |
1,101,839
-63,161
| -5% | -$6.95M | 0.29% | 81 |
|
|
2022
Q3 | $68.7M | Buy |
+1,165,000
| New | +$68.7M | 0.17% | 141 |
|
|
2021
Q4 | – | Sell |
-347,315
| Closed | -$8.24M | – | 1128 |
|
|
2021
Q3 | $8.24M | Sell |
347,315
-27,685
| -7% | -$656K | 0.02% | 752 |
|
|
2021
Q2 | $9.21M | Sell |
375,000
-100,000
| -21% | -$2.46M | 0.02% | 720 |
|
|
2021
Q1 | $8.67M | Buy |
+475,000
| New | +$8.67M | 0.02% | 719 |
|